← FDA DRUG APPROVALS

FDA ANDA · ANDA206688

SODIUM BICARBONATE

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA206688
TYPE
ANDA
ORIGINAL APPROVAL
2025-08-25
LATEST ACTION
2025-08-25
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

SODIUM BICARBONATEPrescription
SODIUM BICARBONATE 2.5MEQ/5ML (0.5MEQ/ML) · SOLUTION · INTRAVENOUS
SODIUM BICARBONATEPrescription
SODIUM BICARBONATE 50MEQ/50ML (1MEQ/ML) · SOLUTION · INTRAVENOUS

Approval history

2025-08-25UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →